Cargando…

Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy

BACKGROUND: The liver has the remarkable capacity to regenerate in order to compensate for lost or damaged hepatic tissue. However, pre-existing pathological abnormalities, such as hepatic steatosis (HS), inhibits the endogenous regenerative process, becoming an obstacle for liver surgery and living...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezquer, Fernando, Bahamonde, Javiera, Huang, Ya-Lin, Ezquer, Marcelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5273822/
https://www.ncbi.nlm.nih.gov/pubmed/28129776
http://dx.doi.org/10.1186/s13287-016-0469-y
_version_ 1782501789148381184
author Ezquer, Fernando
Bahamonde, Javiera
Huang, Ya-Lin
Ezquer, Marcelo
author_facet Ezquer, Fernando
Bahamonde, Javiera
Huang, Ya-Lin
Ezquer, Marcelo
author_sort Ezquer, Fernando
collection PubMed
description BACKGROUND: The liver has the remarkable capacity to regenerate in order to compensate for lost or damaged hepatic tissue. However, pre-existing pathological abnormalities, such as hepatic steatosis (HS), inhibits the endogenous regenerative process, becoming an obstacle for liver surgery and living donor transplantation. Recent evidence indicates that multipotent mesenchymal stromal cells (MSCs) administration can improve hepatic function and increase the potential for liver regeneration in patients with liver damage. Since HS is the most common form of chronic hepatic illness, in this study we evaluated the role of MSCs in liver regeneration in an animal model of severe HS with impaired liver regeneration. METHODS: C57BL/6 mice were fed with a regular diet (normal mice) or with a high-fat diet (obese mice) to induce HS. After 30 weeks of diet exposure, 70% hepatectomy (Hpx) was performed and normal and obese mice were divided into two groups that received 5 × 10(5) MSCs or vehicle via the tail vein immediately after Hpx. RESULTS: We confirmed a significant inhibition of hepatic regeneration when liver steatosis was present, while the hepatic regenerative response was promoted by infusion of MSCs. Specifically, MSC administration improved the hepatocyte proliferative response, PCNA-labeling index, DNA synthesis, liver function, and also reduced the number of apoptotic hepatocytes. These effects may be associated to the paracrine secretion of trophic factors by MSCs and the hepatic upregulation of key cytokines and growth factors relevant for cell proliferation, which ultimately improves the survival rate of the mice. CONCLUSIONS: MSCs represent a promising therapeutic strategy to improve liver regeneration in patients with HS as well as for increasing the number of donor organs available for transplantation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13287-016-0469-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5273822
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52738222017-02-01 Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy Ezquer, Fernando Bahamonde, Javiera Huang, Ya-Lin Ezquer, Marcelo Stem Cell Res Ther Research BACKGROUND: The liver has the remarkable capacity to regenerate in order to compensate for lost or damaged hepatic tissue. However, pre-existing pathological abnormalities, such as hepatic steatosis (HS), inhibits the endogenous regenerative process, becoming an obstacle for liver surgery and living donor transplantation. Recent evidence indicates that multipotent mesenchymal stromal cells (MSCs) administration can improve hepatic function and increase the potential for liver regeneration in patients with liver damage. Since HS is the most common form of chronic hepatic illness, in this study we evaluated the role of MSCs in liver regeneration in an animal model of severe HS with impaired liver regeneration. METHODS: C57BL/6 mice were fed with a regular diet (normal mice) or with a high-fat diet (obese mice) to induce HS. After 30 weeks of diet exposure, 70% hepatectomy (Hpx) was performed and normal and obese mice were divided into two groups that received 5 × 10(5) MSCs or vehicle via the tail vein immediately after Hpx. RESULTS: We confirmed a significant inhibition of hepatic regeneration when liver steatosis was present, while the hepatic regenerative response was promoted by infusion of MSCs. Specifically, MSC administration improved the hepatocyte proliferative response, PCNA-labeling index, DNA synthesis, liver function, and also reduced the number of apoptotic hepatocytes. These effects may be associated to the paracrine secretion of trophic factors by MSCs and the hepatic upregulation of key cytokines and growth factors relevant for cell proliferation, which ultimately improves the survival rate of the mice. CONCLUSIONS: MSCs represent a promising therapeutic strategy to improve liver regeneration in patients with HS as well as for increasing the number of donor organs available for transplantation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13287-016-0469-y) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-28 /pmc/articles/PMC5273822/ /pubmed/28129776 http://dx.doi.org/10.1186/s13287-016-0469-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Ezquer, Fernando
Bahamonde, Javiera
Huang, Ya-Lin
Ezquer, Marcelo
Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy
title Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy
title_full Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy
title_fullStr Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy
title_full_unstemmed Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy
title_short Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy
title_sort administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5273822/
https://www.ncbi.nlm.nih.gov/pubmed/28129776
http://dx.doi.org/10.1186/s13287-016-0469-y
work_keys_str_mv AT ezquerfernando administrationofmultipotentmesenchymalstromalcellsrestoresliverregenerationandimprovesliverfunctioninobesemicewithhepaticsteatosisafterpartialhepatectomy
AT bahamondejaviera administrationofmultipotentmesenchymalstromalcellsrestoresliverregenerationandimprovesliverfunctioninobesemicewithhepaticsteatosisafterpartialhepatectomy
AT huangyalin administrationofmultipotentmesenchymalstromalcellsrestoresliverregenerationandimprovesliverfunctioninobesemicewithhepaticsteatosisafterpartialhepatectomy
AT ezquermarcelo administrationofmultipotentmesenchymalstromalcellsrestoresliverregenerationandimprovesliverfunctioninobesemicewithhepaticsteatosisafterpartialhepatectomy